AT-527
AT-01B-001
Phase 1 small_molecule completed
Quick answer
AT-527 for Chronic Hepatitis C is a Phase 1 program (small_molecule) at Atea Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atea Pharmaceuticals
- Indication
- Chronic Hepatitis C
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed